Exploring Lurasidone for Bipolar Depression and New Treatments in Psychiatry

This chapter analyzes lurasidone's effectiveness and tolerability as a treatment for bipolar depression, comparing it with other medications like cariprazine and lumateperone. It also introduces Cobenify, a recently FDA-approved medication for schizophrenia, emphasizing its innovative mechanism targeting muscarinic receptors.